Sanofi-Aventis US LLC

General

Total Cases210
Active Cases5
Patents373
CourtsD. DelawareD. New JerseyC.D. California
TypeOperating Company
Elite Ratings
--
sanofi.us
sanofi-aventis
sanofi-aventis

Ratings

Experience
Grade
Trend
DCT
L4
A
PTAB
L5
E
CAFC
L5
A

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
06/17/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
SO ORDERED Granting 1098 Joint Stipulation to Substitute Party and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/17/2024. (nms) (Entered: 06/17/2024)
06/17/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
SO ORDERED Granting 1098 Joint Stipulation to Substitute Party and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/17/2024. (nms) (Entered: 06/17/2024)
06/10/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
Joint Stipulation to Substitute Party and Amend Case Caption, by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc.. (Higgins, James) Modified on 6/10/2024 (nms). Modified on 6/10/2024 (nms). (Entered: 06/10/2024)
06/10/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
Joint Stipulation to Substitute Party and Amend Case Caption, by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc.. (Higgins, James) Modified on 6/10/2024 (nms). Modified on 6/10/2024 (nms). (Entered: 06/10/2024)
06/10/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
CORRECTING ENTRY: The stipulation filed at D.I. 1097 has been removed from the docket per the corrected filing at D.I. 1098 . (nms) (Entered: 06/10/2024)
06/10/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
CORRECTING ENTRY: The stipulation filed at D.I. 1097 has been removed from the docket per the corrected filing at D.I. 1098 . (nms) (Entered: 06/10/2024)
05/24/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
REPLY BRIEF re 1092 MOTION for Review of Taxation of Costs filed by Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Czerwonka, Scott) (Entered: 05/24/2024)
05/24/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
REPLY BRIEF re 1092 MOTION for Review of Taxation of Costs filed by Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Czerwonka, Scott) (Entered: 05/24/2024)
05/14/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
ANSWERING BRIEF in Opposition re 1092 MOTION for Review of Taxation of Costs, filed by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc.. Reply Brief due date per Order re D.I. 1094 5/24/2024. (Higgins, James) Modified on 5/21/2024 (nms). (Entered: 05/14/2024)
05/14/24
Amgen Inc v. Sanofi
1:14-CV-01317
 (
D. DE
)
ANSWERING BRIEF in Opposition re 1092 MOTION for Review of Taxation of Costs, filed by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc.. Reply Brief due date per Order re D.I. 1094 5/24/2024. (Higgins, James) Modified on 5/21/2024 (nms). (Entered: 05/14/2024)